HIV treatment identified as potential future therapy for FA – Ataxia

HIV treatment identified as potential future therapy for FA

HIV treatment identified as potential future therapy for FA

A recent study has found that an anti-viral drug, currently in use as a therapy for HIV may be a potential future candidate for Friedreich’s ataxia (FA) therapy. FA is caused by mutation of the frataxin gene, leading to decreased frataxin expression, mitochondrial dysfunction and oxidative stress. Since frataxin levels influence disease severity, the main goal of therapy for FA is to try and increase frataxin levels.

The study searched a library of drugs which had already been approved by the food and drug administration (FDA) to determine which ones might be able to increase frataxin levels. They found that etravirine can lead to a significant increase in frataxin levels in cells derived from FA patients, which was comparable to the levels in cells unaffected by FA.

The researchers commented: ‘Considering its excellent safety profile along with its ability to increase frataxin levels and correct some of the disease?related defects, etravirine represents a promising candidate as a therapeutic for Friedreich’s ataxia.’

For more information view the study abstract here.

Posted on 25/01/2019


Something went wrong. Please check your entries and try again.
fundraise image


Take part in a challenge or create your fundraiser. Every penny you raise will help those affected by ataxia.

Donate Image


To make either a one off or recurring donation which will help fund research into treatments and cures and supports those affected ataxia

Volunteer Image


Support the ataxia community and volunteer with Ataxia UK. From social media to telephone befriending, there are loads of ways you can make a difference to someone's life.

Donate Now
Welcome to our new site! We hope you like it.
As it's brand new, there may be a few temporary glitches such as broken links - we are working on getting these all fixed ASAP. If you'd like to give us any feedback or let us know if something isn't quite right, please email
Scroll to Top